vTv Therapeutics Inc - ESG Rating & Company Profile powered by AI
The webpage of vTv Therapeutics Inc is assembled by All Street Sevva using leading AI. The ESG score covers seventeen United Nations Sustainable Development Goals including: 'No Poverty', 'Responsible Production & Consumption' and 'Life below Water'. This webpage contains a Q&A table about vTv Therapeutics Inc.
vTv Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 2.7, social score of 6.4 and governance score of 6.0.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 724 | Skye Bioscience Inc | 5.1 | High |
| 724 | Xbrane Biopharma AB | 5.1 | High |
| 744 | vTv Therapeutics Inc | 5.0 | High |
| 744 | CSL Ltd | 5.0 | High |
| 744 | CStone Pharmaceuticals | 5.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does vTv Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes vTv Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes vTv Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes vTv Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes vTv Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes vTv Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes vTv Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes vTv Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid vTv Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes vTv Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas vTv Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes vTv Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes vTv Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs vTv Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes vTv Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes vTv Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes vTv Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for vTv Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approach to activating the Nrf2 pathway for the treatment of chronic diseases associated with oxidative stress; azeliragon, a RAGE antagonist for inflammatory lung diseases, including severe COVID-19, as well as for pancreatic and breast cancers; and HPP971, an Nrf2 activator for renal diseases through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc. also has license and research agreements with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; and Novo Nordisk A/S. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated.